Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Solitario net loss widens to $1.83 million in Q2 2026; exploration expense more than doubled to $1.51 million

Solitario net loss widens to $1.83 million in Q2 2026; exploration expense more than doubled to $1.51 million

ReutersReuters2026/08/06 16:17
  • Solitario posted a net loss of USD 1.83 million for the quarter ended June 30, 2026, widening from USD 943,000 a year earlier.
  • Exploration expense more than doubled to USD 1.51 million, driven by Golden Crest spending of USD 1.4 million as drilling began in May.
  • Interest and dividend income rose to USD 77,000 from USD 52,000, while realized and unrealized gains on marketable equity securities fell to USD 56,000 from USD 201,000.
  • Cash and short-term investments totaled USD 9.01 million at June 30, 2026, including USD 8.5 million in a money market account.
  • Net proceeds from stock issuance under the ATM program were USD 2.65 million in the first half, with another USD 228,000 from a Newmont private placement.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Solitario Resources Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001654954-26-007347), on August 06, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.

智通财经2026/08/29 03:22
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Blue Owl (OWL.US) teams up with PIMCO to tailor a $2.4 billion GPU financing for IREN (IREN.US)

A $2.4 billions debt financing round, led by funds under Blue Owl Capital Inc., has been finalized. The funds will be allocated to cloud service provider IREN Ltd. to purchase NVIDIA's Blackwell Ultra GPUs, supporting the development of its data center campus in Canada.

智通财经2026/08/29 02:27
Blue Owl (OWL.US) teams up with PIMCO to tailor a $2.4 billion GPU financing for IREN (IREN.US)